Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis

NCT00004990 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Glomerulonephritis
Nephrotic Syndrome

Interventions

DRUG: Dexamethasone

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)